JP2023552790A5 - - Google Patents
Info
- Publication number
- JP2023552790A5 JP2023552790A5 JP2023534646A JP2023534646A JP2023552790A5 JP 2023552790 A5 JP2023552790 A5 JP 2023552790A5 JP 2023534646 A JP2023534646 A JP 2023534646A JP 2023534646 A JP2023534646 A JP 2023534646A JP 2023552790 A5 JP2023552790 A5 JP 2023552790A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124396P | 2020-12-11 | 2020-12-11 | |
| US63/124,396 | 2020-12-11 | ||
| PCT/US2021/062824 WO2022125908A1 (en) | 2020-12-11 | 2021-12-10 | Anti-pd-l1 immunoconjugates, and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023552790A JP2023552790A (ja) | 2023-12-19 |
| JPWO2022125908A5 JPWO2022125908A5 (https=) | 2024-12-11 |
| JP2023552790A5 true JP2023552790A5 (https=) | 2024-12-11 |
Family
ID=79288110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534646A Pending JP2023552790A (ja) | 2020-12-11 | 2021-12-10 | 抗ｐｄ－ｌ１イムノコンジュゲート、及びそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240033370A1 (https=) |
| EP (1) | EP4259209A1 (https=) |
| JP (1) | JP2023552790A (https=) |
| KR (1) | KR20230118149A (https=) |
| CN (1) | CN116723866A (https=) |
| AU (1) | AU2021398552A1 (https=) |
| CA (1) | CA3200168A1 (https=) |
| IL (1) | IL303491A (https=) |
| WO (1) | WO2022125908A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118475372A (zh) * | 2021-10-29 | 2024-08-09 | 博尔特生物治疗药物有限公司 | 具有半胱氨酸突变抗体的tlr激动剂免疫缀合物及其用途 |
| WO2024173387A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| CA2399940A1 (en) | 2000-04-13 | 2001-10-25 | The Rockefeller University | Enhancement of antibody-mediated immune responses |
| KR101270829B1 (ko) | 2004-09-23 | 2013-06-07 | 제넨테크, 인크. | 시스테인 유전자조작 항체 및 접합체 |
| WO2006073921A2 (en) | 2004-12-30 | 2006-07-13 | The Rockefeller University | Compositions and methods for enhanced dendritic cell maturation and function |
| US20080286819A1 (en) | 2005-11-07 | 2008-11-20 | Ravetch Jeffrey V | Reagents, Methods and Systems for Selecting a Cytotoxic Antibody or Variant Thereof |
| EP2144628B1 (en) | 2007-05-08 | 2012-10-17 | Genentech, Inc. | Cysteine engineered anti-muc16 antibodies and antibody drug conjugates |
| MX2010003718A (es) | 2007-10-19 | 2010-04-21 | Genentech Inc | Anticuerpos anti-tenb2 producidos por ingenieria de cisteina y conjugados de farmaco y anticuerpo. |
| JP5889912B2 (ja) | 2010-11-17 | 2016-03-22 | ジェネンテック， インコーポレイテッド | アラニニルメイタンシノール抗体コンジュゲート |
| US9676863B2 (en) | 2014-02-10 | 2017-06-13 | Merck Patent Gmbh | Targeted TGFβ inhibitors |
| MY189836A (en) | 2014-11-21 | 2022-03-11 | Bristol Myers Squibb Co | Antibodies against cd73 and uses thereof |
| AU2017259654B2 (en) * | 2016-05-06 | 2020-02-27 | Shanghai De Novo Pharmatech Co., Ltd. | Benzazepine derivative, preparation method, pharmaceutical composition and use thereof |
| WO2018140831A2 (en) * | 2017-01-27 | 2018-08-02 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| US20200113912A1 (en) * | 2018-09-12 | 2020-04-16 | Silverback Therapeutics, Inc. | Methods and Compositions for the Treatment of Disease with Immune Stimulatory Conjugates |
| AU2020291014B2 (en) * | 2019-06-13 | 2025-06-05 | Bolt Biotherapeutics, Inc. | Aminobenzazepine compounds, immunoconjugates, and uses thereof |
| WO2020252254A1 (en) * | 2019-06-13 | 2020-12-17 | Bolt Biotherapeutics, Inc. | Macromolecule-supported aminobenzazepine compounds |
| CN115996756A (zh) * | 2020-05-08 | 2023-04-21 | 博尔特生物治疗药物有限公司 | 弹性蛋白酶底物肽连接子免疫缀合物及其用途 |
| US20220195066A1 (en) * | 2020-12-11 | 2022-06-23 | Bolt Biotherapeutics, Inc. | Anti-cea immunoconjugates, and uses thereof |
-
2021
- 2021-12-10 WO PCT/US2021/062824 patent/WO2022125908A1/en not_active Ceased
- 2021-12-10 EP EP21840291.5A patent/EP4259209A1/en active Pending
- 2021-12-10 JP JP2023534646A patent/JP2023552790A/ja active Pending
- 2021-12-10 KR KR1020237022941A patent/KR20230118149A/ko active Pending
- 2021-12-10 AU AU2021398552A patent/AU2021398552A1/en active Pending
- 2021-12-10 US US18/038,910 patent/US20240033370A1/en active Pending
- 2021-12-10 CN CN202180080177.5A patent/CN116723866A/zh active Pending
- 2021-12-10 IL IL303491A patent/IL303491A/en unknown
- 2021-12-10 CA CA3200168A patent/CA3200168A1/en active Pending